Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 8Withdrawn 3Unknown 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1Gastroesophageal Reflux 1Barrett Esophagus 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Lansoprazole × Clear all
NCT04400136 2020-05-22

PPI Therapy Impact on GERD After Sleeve Gastrectomy

University of Roma La Sapienza

Phase EARLY_PHASE1 Unknown
45 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT02388581 2016-03-25

First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL

National Health Research Institutes, Taiwan

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡